37th EDRN Steering Committee Meeting/EDRN Gastrointestinal Cancers Collaborative Group Meeting Draft Agenda

Tuesday, October 19, 2021

10 a.m. to 5:00 p.m. Eastern Daylight Time

Chair: Robert Schoen, MD, University of Pittsburgh

Co-chair: Brian Haab, PhD, Van Andel Research Institute

NCI Program Directors:   Jo Ann Rinaudo, PhD, and Matthew Young, PhD, National Cancer Institute

 

Agenda

 

EDRN GI Colon & Esophageal Group

 

Potential Clinical Utility Trial

10:00 a.m. – 10:45 a.m.

Clinical Utility Studies

Moderator:

Sanford  Markowitz, MD, PhD, Case Western Reserve University

Discussion of Potential Clinical Utility Trials:

o   Clinical applications

o   Trial design

10:45 a.m. - 2:00 p.m.

Team Projects and Core Funds

  • What was accomplished and what remains to be done
  • Feasibility of completion
  • Lessons learned
  • Recommendations for improvements

10:45  a.m. – 11:15 a.m.

01: Fred Hutch CVC Colon Cancer Marker Update

Paul Lampe, PhD, Fred Hutchinson Cancer Research Center

11:15 a.m. - 11:30 a.m.

 

Q&A

11:30 a.m. – 11:45 a.m.

02: Case EDRN Team Projects Report

Helen Moinova, PhD, Case Western Reserve University

11:45 a.m. - 12:00 p.m.

03: Methylated Genes: Emerging Colon Adenoma Risk Prediction Biomarkers

William Grady, MD, Fred Hutchinson Cancer Research Center

12:00 p.m. - 12:15 p.m.

Q&A for both presentations

12:15 p.m. - 12:30 p.m.

Break

 12:30 p.m. – 12:45 p.m.

04: Blood-based AA Detection

Cristian Tomasetti, PhD, The Johns Hopkins School of Medicine

12:45 p.m. - 1:00 p.m.

05: Morphomic Biomarkers of CRC Recurrence

o   Stewart Wang, MD, University of Michigan

o   Grace Su, MD, University of Michigan                                                                       

1:00 p.m. - 1:15 p.m

Q&A for both presentations

1:15 p.m. - 1:45 p.m.

06: GLNE

Robert Bresalier, MD, The University of Texas MD Anderson Cancer Center

1:45 p.m. - 2:00 p.m

Q&A

EDRN GI PDAC Group 

2:00 p.m. - 4:00 p.m.

Team Projects and Core Funds

  • What was accomplished and what remains to be done
  • Feasibility of completion
  • Lessons learned
  • Recommendations for improvements

2:00  p.m. – 2:45 p.m.

07: Bake-off #1 and Bake-off # 2

Ying Huang, PhD, Fred Hutchinson Cancer Research Center

 

2:45 p.m. – 3:30 p.m.

08: Bake-off #3 (Presymptomatic and PLCO Samples)

Brian Haab, PhD, Van Andel Research Institute

 

3:30 p.m. – 3:45 p.m.

09: Update on Pancreatic Cyst Reference Set

Randy Brand, MD, University of Pittsburgh Medical Center

 

 

3:45 p.m. – 4:00 p.m.

10: Challenges and opportunities for radiomics and AI for early detection of pancreatic ductal adenocarcinoma (PDAC)

Eugene Koay, MD, PhD, The University of Texas MD Anderson Cancer Center

Potential Clinical Utility Trial

4:00 p.m. – 5:00 p.m.


 

Clinical Utility Studies

Moderator: Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center

Discussion of Potential Clinical Utility Trials:

o   Clinical applications

o   Trial design

 

5:00 p.m.

Adjourn for the day

Version 5.1.1